These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 3147046)

  • 1. Opioid peptides and primary biliary cirrhosis.
    Thornton JR; Losowsky MS
    BMJ; 1988 Dec; 297(6662):1501-4. PubMed ID: 3147046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe opioid withdrawal syndrome after a single dose of nalmefene.
    Donnerstag N; Schneider T; Lüthi A; Taegtmeyer A; Raetz Bravo A; Mehlig A
    Eur J Clin Pharmacol; 2015 Aug; 71(8):1025-6. PubMed ID: 26050241
    [No Abstract]   [Full Text] [Related]  

  • 3. Delayed opioid withdrawal-like reaction in primary biliary cirrhosis following naloxone therapy.
    Shawcross DL; Jalan R
    Gastroenterology; 2001 Sep; 121(3):743-4. PubMed ID: 11547785
    [No Abstract]   [Full Text] [Related]  

  • 4. Liver transplantation for intractable pruritus is contraindicated before an adequate trial of opiate antagonist therapy.
    Neuberger J; Jones EA
    Eur J Gastroenterol Hepatol; 2001 Nov; 13(11):1393-4. PubMed ID: 11692070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nalmefene and Opioid Withdrawal Syndrome: Analysis of the Global Pharmacovigilance Database for Adverse Drug Reactions].
    Dahmke H; Kupferschmidt H; Kullak-Ublick GA; Weiler S
    Praxis (Bern 1994); 2015 Oct; 104(21):1129-34. PubMed ID: 26463904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methionine-enkephalin concentrations correlate with stage of disease but not pruritus in patients with primary biliary cirrhosis.
    Spivey JR; Jorgensen RA; Gores GJ; Lindor KD
    Am J Gastroenterol; 1994 Nov; 89(11):2028-32. PubMed ID: 7942730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study.
    Wolfhagen FH; Sternieri E; Hop WC; Vitale G; Bertolotti M; Van Buuren HR
    Gastroenterology; 1997 Oct; 113(4):1264-9. PubMed ID: 9322521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Open-label trial of oral nalmefene therapy for the pruritus of cholestasis.
    Bergasa NV; Schmitt JM; Talbot TL; Alling DW; Swain MG; Turner ML; Jenkins JB; Jones EA
    Hepatology; 1998 Mar; 27(3):679-84. PubMed ID: 9500694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid substitution therapy or hidden opioids are a minefield for nalmefene: an atypical case series of 11 patients in Lorraine.
    Yéléhé-Okouma M; Martini H; Lemarié J; Labroca P; Petitpain N; Gibaja V; Paille F; Gillet P
    Fundam Clin Pharmacol; 2017 Oct; 31(5):574-579. PubMed ID: 28322465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Florid opioid withdrawal-like reaction precipitated by naltrexone in a patient with chronic cholestasis.
    Jones EA; Dekker LR
    Gastroenterology; 2000 Feb; 118(2):431-2. PubMed ID: 10648471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of nalmefene glucuronide as a selective gut opioid antagonist.
    Cheskin LJ; Chami TN; Johnson RE; Jaffe JH
    Drug Alcohol Depend; 1995 Aug; 39(2):151-4. PubMed ID: 8529534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naltrexone: a case report of pruritus from an antipruritic.
    Sullivan JR; Watson A
    Australas J Dermatol; 1997 Nov; 38(4):196-8. PubMed ID: 9431714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical trial to determine if corelease of morphine and naltrexone from crushed extended-release capsules induces withdrawal in opioid-dependent patients: a descriptive analysis of six patients.
    Setnik B; Roland CL; Goli V; Sommerville K; Webster L
    J Opioid Manag; 2013; 9(2):139-50. PubMed ID: 23709323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nalmefene Mistakenly Prescribed to Reduce Alcohol Consumption in Patients Under Buprenorphine Substitution Therapy Resulting in Acute Opioid Withdrawal: Management in an Emergency Setting.
    Pélissier F; Rougé Bugat ME; Nubukpo P; Franchitto N
    J Clin Psychopharmacol; 2016 Feb; 36(1):100-3. PubMed ID: 26658085
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of precipitated opiate withdrawal syndrome induced by nalmefene mistakenly prescribed in opiate-dependent patients: a review for clinicians.
    Franchitto N; Jullian B; Salles J; Pelissier F; Rolland B
    Expert Opin Drug Metab Toxicol; 2017 Jun; 13(6):669-677. PubMed ID: 28343423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Withdrawal syndrome after co-medication of opioid maintenance therapy with nalmefene: unrecognized interaction.
    Diot C; Eiden C; Roussin A; Batisse A; Boucher A; Chavant F; Daveluy A; Donadieu-Rigole H; Peyrière H;
    Eur J Clin Pharmacol; 2015 Dec; 71(12):1539-40. PubMed ID: 26329380
    [No Abstract]   [Full Text] [Related]  

  • 17. Withdrawal syndrome caused by naltrexone in opioid abusers.
    Hassanian-Moghaddam H; Afzali S; Pooya A
    Hum Exp Toxicol; 2014 Jun; 33(6):561-7. PubMed ID: 23690227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unintentional rapid opioid detoxification: case report.
    Singh SM; Sharma B
    Psychiatr Danub; 2009 Mar; 21(1):65-7. PubMed ID: 19270623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pruritus and fatigue in primary biliary cirrhosis.
    Bergasa NV; Mehlman JK; Jones EA
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):643-55. PubMed ID: 10976020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naltrexone- or Nalmefene-Related Buprenorphine Withdrawal: Treat It With… More Buprenorphine.
    Lescut C; Gaboriau L; Carton L; Rolland B
    J Clin Psychopharmacol; 2017 Oct; 37(5):631-633. PubMed ID: 28806388
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.